Gateway Investment Advisers LLC Amgen Inc Transaction History

Gateway Investment Advisers LLC

$9 Billion
Q3 2024

A detailed history of Gateway Investment Advisers LLC transactions in Amgen Inc stock. As of the latest transaction made, Gateway Investment Advisers LLC holds 144,731 shares of AMGN stock, worth $41 Million. This represents 0.52% of its overall portfolio holdings.

Number of Shares

144,731

Previous 148,695 2.67%

Holding current value

$41 Million

Previous $46.5 Million 0.37%

% of portfolio

0.52%

Previous 0.53%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 10, 2024	SELL	$309.38 - $337.38 $1.23 Million - $1.34 Million	-3,964 Reduced 2.67%	144,731 $46.6 Million
Q2 2024 Jul 12, 2024	SELL	$262.75 - $319.31 $282,193 - $342,938	-1,074 Reduced 0.72%	148,695 $46.5 Million
Q1 2024 Apr 12, 2024	SELL	$268.87 - $324.56 $819,784 - $989,583	-3,049 Reduced 2.0%	149,769 $42.6 Million
Q4 2023 Jan 09, 2024	SELL	$255.7 - $288.46 $537,481 - $606,342	-2,102 Reduced 1.36%	152,818 $44 Million
Q3 2023 Oct 19, 2023	SELL	$218.65 - $271.46 $144,090 - $178,892	-659 Reduced 0.42%	154,920 $41.6 Million
Q2 2023 Jul 13, 2023	SELL	$214.27 - $253.37 $2.2 Million - $2.6 Million	-10,274 Reduced 6.19%	155,579 $34.5 Million
Q1 2023 Apr 11, 2023	SELL	$225.79 - $275.2 $783,491 - $954,944	-3,470 Reduced 2.05%	165,853 $40.1 Million
Q4 2022 Jan 13, 2023	SELL	$229.03 - $291.01 $1.55 Million - $1.97 Million	-6,779 Reduced 3.85%	169,323 $0
Q3 2022 Oct 07, 2022	SELL	$224.46 - $253.15 $4.18 Million - $4.71 Million	-18,612 Reduced 9.56%	176,102 $39.7 Million
Q2 2022 Jul 13, 2022	SELL	$230.71 - $256.74 $461 - $513	-2 Reduced -0.0%	194,714 $47.4 Million
Q1 2022 Apr 14, 2022	BUY	$219.27 - $242.57 $365,084 - $403,879	1,665 Added 0.86%	194,716 $47.1 Million
Q4 2021 Jan 14, 2022	SELL	$198.88 - $227.6 $1.51 Million - $1.73 Million	-7,604 Reduced 3.79%	193,051 $43.4 Million
Q3 2021 Oct 22, 2021	BUY	$212.27 - $248.7 $76,841 - $90,029	362 Added 0.18%	200,655 $42.7 Million
Q2 2021 Jul 13, 2021	SELL	$233.58 - $259.14 $511,073 - $566,998	-2,188 Reduced 1.08%	200,293 $48.8 Million
Q1 2021 Apr 14, 2021	SELL	$221.91 - $258.6 $4.25 Million - $4.95 Million	-19,137 Reduced 8.64%	202,481 $50.4 Million
Q4 2020 Jan 14, 2021	BUY	$216.38 - $257.67 $32,240 - $38,392	149 Added 0.07%	221,618 $51 Million
Q3 2020 Oct 19, 2020	SELL	$234.65 - $260.95 $87,993 - $97,856	-375 Reduced 0.17%	221,469 $56.3 Million
Q2 2020 Jul 15, 2020	SELL	$197.81 - $242.74 $10.7 Million - $13.1 Million	-53,995 Reduced 19.57%	221,844 $52.3 Million
Q1 2020 Apr 13, 2020	SELL	$182.24 - $241.7 $373,592 - $495,485	-2,050 Reduced 0.74%	275,839 $55.9 Million
Q4 2019 Jan 09, 2020	SELL	$189.21 - $243.2 $9.87 Million - $12.7 Million	-52,161 Reduced 15.8%	277,889 $67 Million
Q3 2019 Oct 15, 2019	SELL	$174.11 - $208.62 $8.17 Million - $9.78 Million	-46,903 Reduced 12.44%	330,050 $63.9 Million
Q2 2019 Jul 17, 2019	SELL	$166.7 - $195.41 $3.22 Million - $3.78 Million	-19,325 Reduced 4.88%	376,953 $69.5 Million
Q1 2019 Apr 10, 2019	SELL	$180.87 - $203.88 $832,182 - $938,051	-4,601 Reduced 1.15%	396,278 $75.3 Million
Q4 2018 Jan 14, 2019	BUY	$178.4 - $208.25 $262,961 - $306,960	1,474 Added 0.37%	400,879 $78 Million
Q3 2018 Oct 16, 2018	SELL	$185.29 - $208.89 $450,625 - $508,020	-2,432 Reduced 0.61%	399,405 $82.8 Million
Q2 2018 Jul 11, 2018	SELL	$166.05 - $186.51 $611,562 - $686,916	-3,683 Reduced 0.91%	401,837 $74.2 Million
Q1 2018 Apr 12, 2018	SELL	$169.43 - $198.0 $907,805 - $1.06 Million	-5,358 Reduced 1.3%	405,520 $69.1 Million
Q4 2017 Jan 17, 2018	SELL	$168.79 - $188.59 $6.53 Million - $7.3 Million	-38,708 Reduced 8.61%	410,878 $71.5 Million
Q3 2017 Oct 16, 2017	BUY	$167.29 - $191.0 $75.2 Million - $85.9 Million	449,586	449,586 $83.8 Million

Others Institutions Holding AMGN

# of Institutions

3,119

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $152B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gateway Investment Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gateway Investment Advisers LLC with notifications on news.

Account

Gateway Investment Advisers LLC Amgen Inc Transaction History